Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Recruiting

Phase 2

LetermovirSingle Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06575374

Conditions

Cell Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Letermovir

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-02-20.